Related Experiment Video

Updated: Jun 8, 2026

Whole Genome Sequencing for Rapid Characterization of Rabies Virus Using Nanopore Technology
10:26

Whole Genome Sequencing for Rapid Characterization of Rabies Virus Using Nanopore Technology

Published on: August 18, 2023

Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa

Colin P Sharp1, Marion Vermeulen, Yacouba Nébié

  • 1University of Edinburgh, Edinburgh, Scotland, UK.

Emerging Infectious Diseases
|September 30, 2010
PubMed

Insights

Human parvovirus 4 (PARV4) infections show high antibody prevalence in sub-Saharan Africa, suggesting non-parenteral transmission routes. This finding contrasts with typical Western transmission patterns, highlighting a need for further research into PARV4 epidemiology.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Human parvovirus 4 (PARV4) is typically linked to parenteral exposure in Western nations.
  • Understanding PARV4 transmission is crucial for public health, especially in diverse geographical regions.

Purpose of the Study:

  • To investigate the seroprevalence of antibodies against Human Parvovirus 4 viral protein 2 (PARV4-VP2) in adult populations in sub-Saharan Africa.
  • To explore potential alternative transmission routes for PARV4 beyond parenteral exposure.

Main Methods:

  • Enzyme-Linked Immunosorbent Assay (ELISA) was employed to detect antibodies against PARV4-VP2.
  • Serological testing was conducted on adult populations across Burkina Faso, Cameroon, the Democratic Republic of the Congo, and South Africa.

Main Results:

  • High seropositivity rates for PARV4-VP2 antibodies were observed: Burkina Faso (37%), Cameroon (25%), Democratic Republic of the Congo (35%), and South Africa (20%).
  • The widespread seropositivity indicates significant exposure to PARV4 within these populations.

Conclusions:

  • The frequent seropositivity for PARV4 antibodies in sub-Saharan Africa suggests the existence of alternative transmission routes.
  • Further research is warranted to elucidate non-parenteral transmission pathways of Human Parvovirus 4 in this region.

More Related Videos

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses05:22

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses

Published on: November 4, 2025

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...